Workflow Services Expands Colorectal Cancer Screening Education Program at Pharmacies

Pilot data from software platform shows unique role of community pharmacy as an emerging healthcare hub that can drive awareness and access to preventative care

MADISON, Wis., March 18, 2025 /PRNewswire/ — Workflow Services, a platform to enable pharmacist-led clinical services, announced the successful completion of a one-year pilot program and a nationwide expansion of a Colorectal Cancer Screening Education Program. The goal of this initiative is to educate patients about the importance of colorectal cancer screening in the pharmacy setting.

Colorectal cancer is the second leading cause of cancer-related deaths in the U.S., yet when detected early, it is highly treatable in about 90% of cases.* The expansion of this program has significant potential to bridge the gap in preventive care because of the community pharmacy’s unique position as many Americans’ most accessible, trusted, and frequently visited healthcare provider. Since 25% of Americans don’t have a primary care provider,** many patients lack critical information about health screenings. However, with 90% of Americans living within five miles of a pharmacy, it is a convenient location to provide healthcare information from a trusted source. ***

In the pilot, 92% of the participating pharmacists reported increased proficiency in their ability to educate patients about the impact of colorectal cancer screening. “The data we collected in the pilot shows that we are unlocking a new, impactful healthcare channel,” said Kevin Houlihan, President and CEO of Workflow Services. “Access is one of the major challenges currently confronting the American healthcare system. And we’ve seen that by providing pharmacists with the right tools and guardrails in a platform like Workflow Services, we can make a real difference in closing care gaps and driving health outcomes.”

Following the pilot program’s success, pharmacies across the country will now be able to use the Workflow Services platform to integrate colorectal cancer screening education seamlessly into their patient encounters. By providing a trusted touchpoint for healthcare conversations, pharmacists can help patients take proactive steps toward early cancer detection.

“We’ve designed a low-lift solution that reduces staff burden,” said Rebecca Liggon, PharmD, Director of Pharmacy Engagement at Workflow Services. “It allows pharmacists to easily support colorectal cancer screening with minimal disruption, backed by the necessary education and resources.”

For patients with average risk factors, the American Cancer Society recommends colorectal cancer screening starting at age 45.

*Based on 5-year survival

**Source: National Association of Community Health Centers

***Source: National Community Pharmacists Association

About Workflow Services

Workflow Services is an end-to-end software platform that helps pharmacies unlock their full potential as community healthcare destinations. The company’s solutions employ exclusive approaches to securely capture and integrate medical data to simplify communication and enhance patient care. In 2023, the Food and Drug Administration (FDA) selected Workflow Services as a partner in its Diagnostic Data Program, the first of its kind launched to collect data from point-of-care tests administered nationally in pharmacy settings. To learn more visit LinkedIn or www.workflowservices.com.

Media Contact:
John Flaherty

(773) 799-8200
392126@email4pr.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/workflow-services-expands-colorectal-cancer-screening-education-program-at-pharmacies-302404895.html

SOURCE Workflow Services

Staff

Recent Posts

What Is the Best GLP-1 Supplement for Weight Loss? Industry Analysis Reveals Probiotic Akkermansia Formulas as Affordable Ozempic Alternatives

Health Journey Addresses 'Best GLP-1 Supplement' Question with Akkermansia-Based Formula Analysis as Six-Month Costs Compare…

7 hours ago

After Trump’s Marijuana Executive Order, Will the DEA Face a Court Imposed Deadline from MMJ’s Writ of Mandamus?

After President Trump's Marijuana Executive Order, Will the DEA Act-or Be Compelled by the Courts?"Despite…

1 day ago

Black Book Research Releases Its 2026 Annual Methodology and Governance Statement for Healthcare IT Vendor Rankings

Boards and executive buyers are raising the 2026 bar for all product and service rankings…

1 day ago

Black Book Research Releases Its 2026 Annual Methodology and Governance Statement for Healthcare IT Vendor Rankings

Boards and executive buyers are raising the 2026 bar for all product and service rankings…

1 day ago

Awake Breast Augmentation: Gruber Plastic Surgery Highlights Live Implant Sizing Under Local Anesthesia With No Sedation for Eligible Patients

Tampa based Celebrity Board-Certified Plastic Surgeon Dr. Meegan Gruber expands an interactive approach that allows…

1 day ago